Metformin group also showed better liver function indicators (higher platelet counts, lower prothrombin time, lower bilirubin, better Albumin-Bilirubin [ALBI] grades32), higher BCLC staging, and larger tumor size. This evidence concerns the gene F2 and neoplasm.